Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Vericel - 28 Year Stock Price History | VCEL

Historical daily share price chart and data for Vericel since 1997 adjusted for splits and dividends. The latest closing stock price for Vericel as of July 15, 2025 is 37.10.
  • The all-time high Vericel stock closing price was 1410.00 on September 24, 1997.
  • The Vericel 52-week high stock price is 63.00, which is 69.8% above the current share price.
  • The Vericel 52-week low stock price is 36.94, which is 0.4% below the current share price.
  • The average Vericel stock price for the last 52 weeks is 48.08.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Vericel Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 47.0594 55.1100 61.8000 37.1000 37.1000 -32.43%
2024 47.3396 34.8800 59.1100 32.5200 54.9100 54.20%
2023 32.8520 25.1300 39.2500 23.8500 35.6100 35.19%
2022 29.1386 41.0700 43.2900 17.6500 26.3400 -32.98%
2021 49.4763 30.9300 67.8100 30.9300 39.3000 27.27%
2020 17.2506 17.4900 31.5000 7.2500 30.8800 77.47%
2019 17.4562 17.7300 20.2900 13.7700 17.4000 0.00%
2018 11.8845 5.9000 18.4400 5.7000 17.4000 219.27%
2017 3.5069 2.9000 6.0000 2.5000 5.4500 81.67%
2016 2.6384 2.5300 6.0800 1.7850 3.0000 16.28%
2015 3.0825 3.1500 3.9500 1.7100 2.5800 -15.13%
2014 3.5103 3.3900 6.4900 2.6100 3.0400 -5.88%
2013 11.9065 26.8000 28.2000 3.2100 3.2300 -87.18%
2012 36.9831 36.2000 52.8000 23.0000 25.2000 -30.77%
2011 50.2729 53.6000 65.4000 35.8000 36.4000 -28.91%
2010 36.4176 54.3040 84.0000 26.8000 51.2000 4.07%
2009 63.6713 84.7840 117.5040 41.6000 49.2000 -38.50%
2008 66.5577 85.1200 120.8000 25.6000 80.0000 -3.85%
2007 198.6193 198.4000 252.8000 83.2000 83.2000 -57.72%
2006 236.4738 337.6000 358.4000 177.6000 196.8000 -41.71%
2005 409.5067 219.2000 648.0000 219.2000 337.6000 48.59%
2004 177.3572 220.8000 267.2000 104.0000 227.2000 6.77%
2003 142.7316 75.2000 283.2000 40.0000 212.8000 182.98%
2002 85.6893 158.2400 168.0000 36.8000 75.2000 -52.04%
2001 197.2201 145.0000 384.0000 120.0000 156.8000 12.00%
2000 424.4742 125.0000 1240.0000 115.0000 140.0000 12.00%
1999 270.5456 440.0000 520.0000 70.0000 125.0000 -72.83%
1998 581.0417 760.0000 1020.0000 290.0000 460.0000 -34.29%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.005B $0.237B
Vericel Corporation is focused on developing patient-specific expanded cellular therapies for use in the treatment of patients with severe diseases and conditions. The company markets two autologous cell therapy products in the United States: Carticel (R) for the treatment of cartilage defects in the knee, and Epicel (R) for the treatment of severe burns. It is also developing MACI (TM) for the treatment of cartilage defects in the knee, and ixmyelocel-T for the treatment of advanced heart failure due to ischemic dilated cardiomyopathy. Vericel Corporation, formerly Aastrom Biosciences, Inc., is based in United States.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $222.488B 16.61
Amgen (AMGN) United States $159.715B 14.31
Gilead Sciences (GILD) United States $139.432B 14.48
Vertex Pharmaceuticals (VRTX) United States $121.298B 0.00
Bristol Myers Squibb (BMY) United States $96.341B 6.45
GSK (GSK) United Kingdom $78.393B 9.38
CSL (CSLLY) Australia $77.367B 0.00
Regeneron Pharmaceuticals (REGN) United States $61.604B 14.95
Alnylam Pharmaceuticals (ALNY) United States $41.170B 0.00
Argenex SE (ARGX) Netherlands $34.350B 93.55
BioNTech SE (BNTX) Germany $26.684B 0.00
Royalty Pharma (RPRX) United States $20.376B 8.61
Biogen (BIIB) United States $19.504B 8.41
Insmed (INSM) United States $19.330B 0.00
Illumina (ILMN) United States $15.597B 29.59
Genmab (GNMSF) Denmark $14.203B 14.52
Genmab (GMAB) Denmark $13.768B 15.44
Incyte (INCY) United States $13.546B 102.91
Moderna (MRNA) United States $12.712B 0.00
Exelixis (EXEL) United States $12.430B 21.10
BioMarin Pharmaceutical (BMRN) United States $11.167B 18.14
QIAGEN (QGEN) Netherlands $10.732B 20.88
Ascendis Pharma (ASND) Denmark $10.691B 0.00
Swedish Orphan Biovitrum (BIOVF) Sweden $10.413B 26.59
Exact Sciences (EXAS) United States $10.243B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $8.911B 0.00
Blueprint Medicines (BPMC) United States $8.354B 0.00
Bio-Techne Corp (TECH) United States $8.249B 30.77
Roivant Sciences (ROIV) United Kingdom $7.906B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $7.259B 0.00
Legend Biotech (LEGN) United States $7.248B 0.00
Revolution Medicines (RVMD) United States $7.147B 0.00
Halozyme Therapeutics (HALO) United States $7.104B 13.60
Bio-Rad Laboratories (BIO.B) United States $7.014B 24.41
Anbio Biotechnology (NNNN) Germany $6.858B 0.00
Repligen (RGEN) United States $6.817B 76.31
Jazz Pharmaceuticals (JAZZ) Ireland $6.743B 6.62
TG Therapeutics (TGTX) United States $6.179B 162.17
Guardant Health (GH) United States $6.166B 0.00
Nuvalent (NUVL) United States $6.074B 0.00
Rhythm Pharmaceuticals (RYTM) United States $5.672B 0.00
Axsome Therapeutics (AXSM) United States $5.531B 0.00
Telix Pharmaceuticals (TLX) Australia $5.269B 0.00
Alkermes (ALKS) Ireland $4.896B 13.14
CRISPR Therapeutics AG (CRSP) Switzerland $4.873B 0.00
Vaxcyte (PCVX) United States $4.693B 0.00
Cytokinetics (CYTK) United States $4.608B 0.00
Metsera (MTSR) United States $4.462B 0.00
ADMA Biologics Inc (ADMA) United States $4.460B 33.36
Krystal Biotech (KRYS) United States $4.347B 33.50
Akero Therapeutics (AKRO) United States $4.204B 0.00
Zealand Pharma (ZLDPF) Denmark $4.088B 0.00
Avidity Biosciences (RNA) United States $4.046B 0.00
PTC Therapeutics (PTCT) United States $3.920B 6.82
Arcellx (ACLX) United States $3.853B 0.00
Merus (MRUS) Netherlands $3.850B 0.00
Zai Lab (ZLAB) China $3.808B 0.00
Scholar Rock Holding (SRRK) United States $3.664B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.664B 32.19
Viking Therapeutics (VKTX) United States $3.552B 0.00
Protagonist Therapeutics (PTGX) United States $3.423B 73.64
MoonLake Immunotherapeutics (MLTX) Switzerland $3.256B 0.00
Immunovant (IMVT) United States $3.180B 0.00
Ascentage Pharma Group - (AAPG) China $3.154B 0.00
Kymera Therapeutics (KYMR) United States $2.924B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.831B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.763B 0.00
Alvotech (ALVO) Luxembourg $2.683B 15.35
Mirum Pharmaceuticals (MIRM) United States $2.639B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.570B 0.00
ImmunityBio (IBRX) United States $2.560B 0.00
Apellis Pharmaceuticals (APLS) United States $2.502B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.502B 0.00
Ligand Pharmaceuticals (LGND) United States $2.449B 0.00
Agios Pharmaceuticals (AGIO) United States $2.272B 0.00
Twist Bioscience (TWST) United States $2.265B 0.00
Bavarian Nordic (BVNRY) Denmark $2.193B 11.59
Recursion Pharmaceuticals (RXRX) United States $2.146B 0.00
Denali Therapeutics (DNLI) United States $2.134B 0.00
Beam Therapeutics (BEAM) United States $2.129B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.102B 0.00
Belite Bio (BLTE) United States $2.024B 0.00
Disc Medicine (IRON) United States $2.000B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.993B 13.25
IDEAYA Biosciences (IDYA) United States $1.978B 0.00
CG Oncology (CGON) United States $1.974B 0.00
NovoCure (NVCR) Jersey $1.942B 0.00
Amicus Therapeutics (FOLD) United States $1.921B 208.00
Arcutis Biotherapeutics (ARQT) United States $1.895B 0.00
Sarepta Therapeutics (SRPT) United States $1.890B 0.00
Certara (CERT) United States $1.807B 33.76
Apogee Therapeutics (APGE) United States $1.790B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.773B 0.00
Adaptive Biotechnologies (ADPT) United States $1.755B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.745B 0.00
89BIO (ETNB) United States $1.623B 0.00
Celldex Therapeutics (CLDX) United States $1.551B 0.00
Janux Therapeutics (JANX) United States $1.549B 0.00
Vera Therapeutics (VERA) United States $1.517B 0.00
Travere Therapeutics (TVTX) United States $1.502B 0.00
Edgewise Therapeutics (EWTX) United States $1.465B 0.00
Biohaven (BHVN) United States $1.449B 0.00
GRAIL (GRAL) United States $1.445B 0.00
Mesoblast (MESO) Australia $1.427B 0.00
ANI Pharmaceuticals (ANIP) United States $1.412B 14.55
Viridian Therapeutics (VRDN) United States $1.398B 0.00
Dynavax Technologies (DVAX) United States $1.290B 76.71
AbCellera Biologics (ABCL) Canada $1.265B 0.00
Cogent Biosciences (COGT) United States $1.263B 0.00
Pharvaris (PHVS) Netherlands $1.245B 0.00
Liquidia Technologies (LQDA) United States $1.238B 0.00
Intellia Therapeutics (NTLA) United States $1.238B 0.00
CureVac (CVAC) Germany $1.225B 5.93
MannKind (MNKD) United States $1.225B 25.19
WAVE Life Sciences (WVE) Singapore $1.220B 0.00
Novavax (NVAX) United States $1.129B 2.63
Structure Therapeutics (GPCR) United States $1.122B 0.00
Cidara Therapeutics (CDTX) United States $1.115B 0.00
Praxis Precision Medicines (PRAX) United States $1.092B 0.00
Pacira BioSciences (PCRX) United States $1.079B 10.27
Arcus Biosciences (RCUS) United States $1.022B 0.00
MiMedx (MDXG) United States $1.004B 24.29
Spyre Therapeutics (SYRE) United States $0.989B 0.00
Anavex Life Sciences (AVXL) United States $0.980B 0.00
Mineralys Therapeutics (MLYS) United States $0.979B 0.00
Nurix Therapeutics (NRIX) United States $0.970B 0.00
Sana Biotechnology (SANA) United States $0.952B 0.00
LENZ Therapeutics (LENZ) United States $0.949B 0.00
Zymeworks (ZYME) United States $0.930B 0.00
Oric Pharmaceuticals (ORIC) United States $0.925B 0.00
NeoGenomics (NEO) United States $0.924B 0.00
Niagen Bioscience (NAGE) United States $0.887B 125.11
Jyong Biotech (MENS) Taiwan $0.883B 0.00
Sionna Therapeutics (SION) United States $0.880B 0.00
Replimune (REPL) United States $0.870B 0.00
GH Research (GHRS) Ireland $0.858B 0.00
Geron (GERN) United States $0.853B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.848B 0.00
Trevi Therapeutics (TRVI) United States $0.822B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.808B 0.00
UniQure (QURE) Netherlands $0.797B 0.00
Oculis Holding AG (OCS) Switzerland $0.793B 0.00
AnaptysBio (ANAB) United States $0.792B 0.00
BGM Group (BGM) China $0.786B 0.00
Pharming Group (PHGUF) Netherlands $0.772B 0.00
CorMedix Inc (CRMD) United States $0.770B 51.64
Vir Biotechnology (VIR) United States $0.760B 0.00
ArriVent BioPharma (AVBP) United States $0.748B 0.00
Immatics (IMTX) Germany $0.743B 0.00
Immunome (IMNM) United States $0.740B 0.00
Nuvation Bio (NUVB) United States $0.728B 0.00
MeiraGTx Holdings (MGTX) United States $0.714B 0.00
Gyre Therapeutics (GYRE) United States $0.713B 190.25
Pharming Group (PHAR) Netherlands $0.709B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.705B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.702B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.700B 0.00
Maze Therapeutics (MAZE) United States $0.689B 0.00
Iovance Biotherapeutics (IOVA) United States $0.671B 0.00
Urogen Pharma (URGN) United States $0.668B 0.00
Tango Therapeutics (TNGX) United States $0.660B 0.00
Stoke Therapeutics (STOK) United States $0.658B 15.27
Prime Medicine (PRME) United States $0.646B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Dianthus Therapeutics (DNTH) United States $0.644B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.633B 0.00
Upstream Bio (UPB) United States $0.631B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.629B 0.00
Arbutus Biopharma (ABUS) United States $0.621B 0.00
Keros Therapeutics (KROS) United States $0.592B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.582B 0.00
Tyra Biosciences (TYRA) United States $0.579B 0.00
Precigen (PGEN) United States $0.576B 0.00
Arvinas (ARVN) United States $0.574B 0.00
Sage Therapeutics (SAGE) United States $0.573B 0.00
Castle Biosciences (CSTL) United States $0.563B 38.24
Abivax SA (ABVX) France $0.560B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.560B 0.00
Bicara Therapeutics (BCAX) United States $0.555B 0.00
Kura Oncology (KURA) United States $0.550B 0.00
Zenas BioPharma (ZBIO) United States $0.536B 0.00
Septerna (SEPN) United States $0.535B 0.00
Rapport Therapeutics (RAPP) United States $0.534B 0.00
Opthea (OPT) Australia $0.525B 0.00
Celcuity (CELC) United States $0.521B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.505B 0.00
ATyr Pharma (ATYR) United States $0.492B 0.00
Myriad Genetics (MYGN) United States $0.481B 0.00
Cullinan Therapeutics (CGEM) United States $0.464B 0.00
MBX Biosciences (MBX) United States $0.464B 0.00
Rezolute (RZLT) United States $0.455B 0.00
Fortrea Holdings (FTRE) United States $0.453B 12.52
Kamada (KMDA) Israel $0.447B 26.83
Terns Pharmaceuticals (TERN) United States $0.446B 0.00
REGENXBIO (RGNX) United States $0.436B 0.00
Tectonic Therapeutic (TECX) United States $0.432B 0.00
PureTech Health (PRTC) United States $0.428B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.427B 0.00
Fulcrum Therapeutics (FULC) United States $0.426B 0.00
Cytek Biosciences (CTKB) United States $0.424B 0.00
Solid Biosciences (SLDB) United States $0.424B 0.00
Erasca (ERAS) United States $0.414B 0.00
Compass Therapeutics (CMPX) United States $0.404B 0.00
Emergent Biosolutions (EBS) United States $0.396B 0.00
ITeos Therapeutics (ITOS) United States $0.396B 0.00
Eton Pharmaceuticals (ETON) United States $0.390B 0.00
Northwest Biotherapeutics (NWBO) United States $0.387B 0.00
Vigil Neuroscience (VIGL) United States $0.385B 0.00
Humacyte (HUMA) United States $0.383B 0.00
Astria Therapeutics (ATXS) United States $0.374B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.361B 0.00
Benitec Biopharma (BNTC) United States $0.348B 0.00
Gossamer Bio (GOSS) United States $0.348B 0.00
Prothena (PRTA) Ireland $0.346B 0.00
Absci (ABSI) United States $0.339B 0.00
Aura Biosciences (AURA) United States $0.339B 0.00
Cartesian Therapeutics (RNAC) United States $0.339B 0.00
Amarin (AMRN) Ireland $0.333B 0.00
Inhibrx Biosciences (INBX) United States $0.332B 0.20
ADC Therapeutics SA (ADCT) Switzerland $0.332B 0.00
XOMA Royalty (XOMA) United States $0.332B 0.00
Inventiva S.A (IVA) France $0.331B 0.00
Olema Pharmaceuticals (OLMA) United States $0.330B 0.00
Foghorn Therapeutics (FHTX) United States $0.328B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.326B 0.00
Ocugen (OCGN) United States $0.324B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.324B 65.75
Candel Therapeutics (CADL) United States $0.322B 0.00
Atea Pharmaceuticals (AVIR) United States $0.322B 0.00
Neurogene (NGNE) United States $0.317B 0.00
Palvella Therapeutics (PVLA) United States $0.305B 0.00
Abeona Therapeutics (ABEO) United States $0.303B 0.00
Lifecore Biomedical (LFCR) United States $0.303B 0.00
Vor Biopharma (VOR) $0.299B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.297B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.293B 0.00
Sagimet Biosciences (SGMT) United States $0.290B 0.00
Annexon (ANNX) United States $0.286B 0.00
Allogene Therapeutics (ALLO) United States $0.282B 0.00
DBV Technologies S.A (DBVT) France $0.280B 0.00
Tvardi Therapeutics (TVRD) United States $0.279B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.277B 0.00
Cardiff Oncology (CRDF) United States $0.275B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.273B 0.00
Kodiak Sciences (KOD) United States $0.273B 0.00
Verastem (VSTM) United States $0.273B 0.00
Monopar Therapeutics (MNPR) United States $0.267B 0.00
Aardvark Therapeutics (AARD) United States $0.263B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.261B 0.00
Entrada Therapeutics (TRDA) United States $0.258B 8.40
Codexis (CDXS) United States $0.254B 0.00
Crescent Biopharma (CBIO) United States $0.250B 0.00
Prima BioMed (IMMP) Australia $0.247B 0.00
Third Harmonic Bio (THRD) United States $0.246B 0.00
Adherex Technologies (FENC) United States $0.243B 0.00
Alpha Teknova (TKNO) United States $0.240B 0.00
Editas Medicine (EDIT) United States $0.239B 0.00
MaxCyte (MXCT) United States $0.238B 0.00
ScPharmaceuticals (SCPH) United States $0.237B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.234B 0.00
Semper Paratus Acquisition (TVGN) United States $0.232B 0.00
Design Therapeutics (DSGN) United States $0.227B 0.00
Adocia (ADOCY) France $0.216B 0.00
CARGO Therapeutics (CRGX) United States $0.212B 0.00
AC Immune (ACIU) Switzerland $0.209B 0.00
Neumora Therapeutics (NMRA) United States $0.205B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.201B 0.00
BioStem Technologies (BSEM) $0.201B 8.16
Ventyx Biosciences (VTYX) United States $0.200B 0.00
SELLAS Life Sciences (SLS) United States $0.198B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.197B 0.00
Alumis (ALMS) United States $0.196B 0.00
CytomX Therapeutics (CTMX) United States $0.193B 4.98
Kyverna Therapeutics (KYTX) United States $0.190B 0.00
Voyager Therapeutics (VYGR) United States $0.190B 0.00
GENFIT S.A (GNFT) France $0.190B 0.00
Agenus (AGEN) United States $0.187B 0.00
Bright Minds Biosciences (DRUG) United States $0.181B 0.00
I-Mab (IMAB) United States $0.175B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.173B 0.00
DiaMedica Therapeutics (DMAC) United States $0.172B 0.00
Nuvectis Pharma (NVCT) United States $0.172B 0.00
Puma Biotechnology (PBYI) United States $0.171B 4.48
EnGene Holdings (ENGN) Canada $0.171B 0.00
C4 Therapeutics (CCCC) United States $0.169B 0.00
Alpha Cognition (ACOG) Canada $0.169B 0.00
Black Diamond Therapeutics (BDTX) United States $0.167B 49.00
Alector (ALEC) United States $0.167B 0.00
BioAge Labs (BIOA) United States $0.166B 0.00
Anika Therapeutics (ANIK) United States $0.165B 0.00
MiNK Therapeutics (INKT) United States $0.162B 0.00
Instil Bio (TIL) United States $0.161B 0.00
Caribou Biosciences (CRBU) United States $0.158B 0.00
Innate Pharma S.A (IPHA) France $0.157B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.152B 0.00
Immuneering (IMRX) United States $0.150B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.149B 0.00
Spero Therapeutics (SPRO) United States $0.148B 0.00
Theratechnologies (THTX) Canada $0.145B 0.00
Greenwich LifeSciences (GLSI) United States $0.145B 0.00
Rapt Therapeutics (RAPT) United States $0.144B 0.00
Elicio Therapeutics (ELTX) United States $0.144B 0.00
Molecular Partners AG (MOLN) Switzerland $0.143B 0.00
Compugen (CGEN) Israel $0.142B 0.00
Citius Oncology (CTOR) United States $0.139B 0.00
23andMe Holding (MEHCQ) United States $0.136B 0.00
Nkarta (NKTX) United States $0.134B 0.00
Fate Therapeutics (FATE) United States $0.131B 0.00
Seres Therapeutics (MCRB) United States $0.130B 0.00
Genelux (GNLX) United States $0.128B 0.00
Seer (SEER) United States $0.125B 0.00
Skye Bioscience (SKYE) United States $0.122B 0.00
Actuate Therapeutics (ACTU) United States $0.122B 0.00
Cellectis S.A (CLLS) France $0.120B 0.00
Sangamo Therapeutics (SGMO) United States $0.117B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.116B 0.00
BioHarvest Sciences (BHST) Canada $0.116B 0.00
Tenaya Therapeutics (TNYA) United States $0.116B 0.00
Oncolytics Biotech (ONCY) Canada $0.113B 0.00
IO Biotech (IOBT) Denmark $0.112B 0.00
Coherus Oncology (CHRS) United States $0.110B 0.00
HilleVax (HLVX) United States $0.109B 0.00
TScan Therapeutics (TCRX) United States $0.109B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.103B 0.00
Coya Therapeutics (COYA) United States $0.103B 0.00
TuHURA Biosciences (HURA) United States $0.102B 0.00
Nautilus Biotechnology (NAUT) United States $0.099B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.098B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.098B 0.00
Whitehawk Therapeutics (WHWK) United States $0.097B 0.00
Contineum Therapeutics (CTNM) United States $0.097B 0.00
Climb Bio (CLYM) United States $0.096B 0.00
BeyondSpring (BYSI) United States $0.092B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.090B 0.00
Pliant Therapeutics (PLRX) United States $0.089B 0.00
Zura Bio (ZURA) United States $0.089B 0.00
XBiotech (XBIT) United States $0.088B 0.00
OKYO Pharma (OKYO) $0.087B 0.00
Invivyd (IVVD) United States $0.087B 0.00
Adagene (ADAG) China $0.086B 0.00
Cabaletta Bio (CABA) United States $0.086B 0.00
Elutia (ELUT) United States $0.084B 0.00
EXoZymes (EXOZ) United States $0.082B 0.00
Entera Bio (ENTX) Israel $0.082B 0.00
IGM Biosciences (IGMS) United States $0.081B 0.00
Quince Therapeutics (QNCX) United States $0.081B 0.00
Immix Biopharma (IMMX) United States $0.081B 0.00
Immunic (IMUX) United States $0.080B 0.00
TELA Bio (TELA) United States $0.079B 0.00
Connect Biopharma Holdings (CNTB) United States $0.078B 0.00
Oncobiologics (OTLK) United States $0.078B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.074B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.074B 0.00
Biomea Fusion (BMEA) United States $0.073B 0.00
Alto Neuroscience (ANRO) United States $0.073B 0.00
VistaGen Therapeutics (VTGN) United States $0.069B 0.00
Genenta Science S.p.A (GNTA) Italy $0.069B 0.00
Repare Therapeutics (RPTX) Canada $0.067B 0.00
Opus Genetics (IRD) United States $0.066B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.066B 0.00
Ikena Oncology (IKNA) United States $0.066B 0.00
Forte Biosciences (FBRX) United States $0.065B 0.00
Sutro Biopharma (STRO) United States $0.065B 0.00
Clearside Biomedical (CLSD) United States $0.064B 0.00
Adicet Bio (ACET) United States $0.064B 0.00
MediciNova (MNOV) United States $0.063B 0.00
CervoMed (CRVO) United States $0.062B 0.00
Earth Science Tech (ETST) United States $0.062B 0.00
Quantum Biopharma (QNTM) Canada $0.061B 0.00
InflaRx (IFRX) Germany $0.060B 0.00
ABVC BioPharma (ABVC) United States $0.060B 0.00
Applied Therapeutics (APLT) United States $0.060B 0.00
Cue Biopharma (CUE) United States $0.059B 0.00
Fortress Biotech (FBIO) United States $0.058B 0.00
Werewolf Therapeutics (HOWL) United States $0.058B 0.00
Adverum Biotechnologies (ADVM) United States $0.057B 0.00
PDS Biotechnology (PDSB) United States $0.056B 0.00
Annovis Bio (ANVS) United States $0.056B 0.00
Adlai Nortye (ANL) Cayman Islands $0.056B 0.00
Atara Biotherapeutics (ATRA) United States $0.055B 0.00
Celularity (CELU) United States $0.054B 0.00
VTv Therapeutics (VTVT) United States $0.053B 0.00
Aligos Therapeutics (ALGS) United States $0.053B 0.00
Artiva Biotherapeutics (ARTV) United States $0.053B 0.00
Jasper Therapeutics (JSPR) United States $0.052B 0.00
ZIVO Bioscience (ZIVO) United States $0.052B 0.00
Precision BioSciences (DTIL) United States $0.051B 0.00
Senti Biosciences (SNTI) United States $0.051B 0.00
RenovoRx (RNXT) United States $0.051B 0.00
INmune Bio (INMB) United States $0.050B 0.00
Inovio Pharmaceuticals (INO) United States $0.050B 0.00
Kalaris Therapeutics (KLRS) United States $0.049B 0.00
Renovaro (RENB) United States $0.048B 0.00
Grace Therapeutics (GRCE) Canada $0.046B 0.00
Exicure (XCUR) United States $0.044B 0.00
Rani Therapeutics Holdings (RANI) United States $0.044B 0.00
Scilex Holding (SCLX) United States $0.044B 0.00
Lantern Pharma (LTRN) United States $0.043B 0.00
Mersana Therapeutics (MRSN) United States $0.043B 0.00
Medicus Pharma (MDCX) United States $0.042B 0.00
PepGen (PEPG) United States $0.042B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.041B 0.00
Alterity Therapeutics - (ATHE) Australia $0.041B 0.00
Pluri (PLUR) Israel $0.040B 0.00
Shattuck Labs (STTK) United States $0.039B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.039B 0.00
Xilio Therapeutics (XLO) United States $0.038B 0.00
Cognition Therapeutics (CGTX) United States $0.038B 0.00
KALA BIO (KALA) United States $0.037B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.036B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.035B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.035B 0.00
OnKure Therapeutics (OKUR) United States $0.034B 0.00
Kezar Life Sciences (KZR) United States $0.033B 0.00
Rein Therapeutics (RNTX) United States $0.033B 0.00
Radiopharm Theranostics - (RADX) Australia $0.033B 0.00
CalciMedica (CALC) United States $0.032B 0.00
AN2 Therapeutics (ANTX) United States $0.032B 0.00
Estrella Immunopharma (ESLA) United States $0.032B 0.00
Clene (CLNN) United States $0.031B 0.00
Femasys (FEMY) United States $0.031B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.031B 0.00
CAMP4 Therapeutics (CAMP) United States $0.030B 0.00
Generation Bio (GBIO) United States $0.030B 0.00
Dyadic (DYAI) United States $0.029B 0.00
Ovid Therapeutics (OVID) United States $0.028B 0.00
Dare Bioscience (DARE) United States $0.027B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.027B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.026B 0.00
Boundless Bio (BOLD) United States $0.026B 0.00
FibroBiologics (FBLG) United States $0.025B 0.00
ALX Oncology Holdings (ALXO) United States $0.025B 0.00
SAB Biotherapeutics (SABS) United States $0.025B 0.00
Q32 Bio (QTTB) United States $0.025B 0.00
Cadrenal Therapeutics (CVKD) United States $0.025B 0.00
Tenax Therapeutics (TENX) United States $0.024B 0.00
BioAtla (BCAB) United States $0.023B 0.00
Lisata Therapeutics (LSTA) United States $0.023B 0.00
Elevation Oncology (ELEV) United States $0.023B 0.00
Chemomab Therapeutics (CMMB) Israel $0.022B 0.00
Longeveron (LGVN) United States $0.021B 0.00
Passage Bio (PASG) United States $0.021B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.021B 0.00
Cingulate (CING) United States $0.020B 0.00
Curis (CRIS) United States $0.020B 0.00
Aytu BioPharma (AYTU) United States $0.019B 0.00
Hoth Therapeutics (HOTH) United States $0.019B 0.00
Rallybio (RLYB) United States $0.017B 0.00
Advanced Biomed (ADVB) United States $0.017B 0.00
Promis Neurosciences (PMN) Canada $0.017B 0.00
Gelteq (GELS) Australia $0.017B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.016B 0.00
Allarity Therapeutics (ALLR) United States $0.016B 0.00
Athira Pharma (ATHA) United States $0.016B 0.00
Edesa Biotech (EDSA) Canada $0.015B 0.00
Lexaria Bioscience (LEXX) Canada $0.015B 0.00
HOOKIPA Pharma (HOOK) United States $0.015B 0.00
Synlogic (SYBX) United States $0.015B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.014B 0.00
Synaptogenix (TAOX) United States $0.014B 0.00
MetaVia (MTVA) United States $0.014B 0.00
BRIACELL THERAP (BCTX) Canada $0.014B 0.00
Leap Therapeutics (LPTX) United States $0.014B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.013B 0.00
Beyond Air (XAIR) United States $0.013B 0.00
NextCure (NXTC) United States $0.013B 0.00
Equillium (EQ) United States $0.013B 0.00
BioCardia (BCDA) United States $0.013B 0.00
IBio (IBIO) United States $0.013B 0.00
BioXcel Therapeutics (BTAI) United States $0.012B 0.00
Abpro Holdings (ABP) United States $0.012B 0.00
Biorestorative Therapies (BRTX) United States $0.012B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.012B 0.00
Novogen (KZIA) Australia $0.012B 0.00
Bolt Biotherapeutics (BOLT) United States $0.011B 0.00
Bionano Genomics (BNGO) United States $0.011B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
GeoVax Labs (GOVX) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Cyclerion Therapeutics (CYCN) United States $0.011B 0.00
Mustang Bio (MBIO) United States $0.011B 0.00
LakeShore Biopharma (LSB) China $0.010B 0.00
Sensei Biotherapeutics (SNSE) United States $0.010B 0.00
Artelo Biosciences (ARTL) United States $0.010B 0.00
GENPREX (GNPX) United States $0.010B 0.00
Dogwood Therapeutics (DWTX) United States $0.010B 0.00
Aprea Therapeutics (APRE) United States $0.009B 0.00
Imunon (IMNN) United States $0.009B 0.00
Moleculin Biotech (MBRX) United States $0.009B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.009B 0.00
X4 Pharmaceuticals (XFOR) United States $0.009B 0.00
Intensity Therapeutics (INTS) United States $0.008B 0.00
Turnstone Biologics (TSBX) United States $0.008B 0.00
BioAffinity Technologies (BIAF) United States $0.008B 0.00
Biofrontera (BFRI) United States $0.008B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.008B 0.00
Jade Biosciences (JBIO) United States $0.008B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.007B 0.00
IN8bio (INAB) United States $0.007B 0.00
Evogene (EVGN) Israel $0.007B 0.00
Purple Biotech (PPBT) Israel $0.007B 0.00
Arcadia Biosciences (RKDA) United States $0.006B 0.00
Mainz Biomed (MYNZ) Germany $0.006B 0.00
Portage Biotech (PRTG) $0.006B 0.00
Apollomics (APLM) United States $0.006B 0.00
HCW Biologics (HCWB) United States $0.006B 0.00
180 Life Sciences (ATNF) United States $0.005B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.005B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
Galecto (GLTO) Denmark $0.005B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
Avalon GloboCare (ALBT) United States $0.005B 0.00
VivoSim Labs (VIVS) United States $0.005B 0.00
CNS Pharmaceuticals (CNSP) United States $0.005B 0.00
Dermata Therapeutics (DRMA) United States $0.005B 0.00
GRI Bio (GRI) United States $0.005B 0.00
Tharimmune (THAR) United States $0.005B 0.00
Soligenix (SNGX) United States $0.004B 0.00
Revelation Biosciences (REVB) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.004B 0.00
Adial Pharmaceuticals (ADIL) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
Polyrizon (PLRZ) Israel $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
Onconetix (ONCO) United States $0.003B 0.00
Alzamend Neuro (ALZN) United States $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00